‘Paradigm shift’: Otsuka says High Court must reverse patent extension ruling

Intellectual Property 2026-01-08 4:29 pm By Sam Matthews Melbourne

Otsuka Pharmaceuticals has asked the High Court to overturn a decision revoking its Abilify patent extension, saying the ruling, which limited the extension-of term scheme to active substances only, will “lead to a groundswell of court proceedings”.